Novo gets US backing for Victoza cardiovascular data

21st June 2017 Uncategorised 0

US regulatory advisors are backing the claim that Novo Nordisk’s Victoza reduces cardiovascular risk in patients with diabetes.

More: Novo gets US backing for Victoza cardiovascular data
Source: News